Neuroactive steroids: Effects and risks;Neuroaktive steroide: Wirkungen und risiken

Pharmazie in Unserer Zeit

Volumn 29, Issue 6, 2000, Pages 372-376

  Weiss, Michael ^a   Hess, Sonja ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID RECEPTOR; 5ALPHA PREGNANE 3,20 DIONE; ANDROSTENEDIONE; CHOLESTEROL; CORTICOSTERONE DERIVATIVE; DEOXYCORTICOSTERONE; DIHYDRODEOXYCORTICOSTERONE; ESTRADIOL; NEUROSTEROID; PRASTERONE; PREGNENOLONE; PROGESTERONE; TESTOSTERONE; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG;

BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; NEUROENDOCRINOLOGY; NEUROPSYCHOLOGY; NEUROTRANSMISSION; RISK ASSESSMENT; SHORT SURVEY; STEROIDOGENESIS;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; RISK FACTORS; STEROIDS;

EID: 0034489780     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/1615-1003(200012)29:6<372::AID-PAUZ372>3.0.CO;2-J     Document Type: Short Survey

References (10)

1. Neurosteroids: Oligodendrocyte mitochondria convert cholesterol to pregnenolone
2. Neuroactive steroids: Mechanism of action and neuropsychological perspectives
3. A receptors
4. A receptor function
5. A receptor function through distinct sites
6. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity
7. Neurotherapeutics: Emerging strategies
8. Allopregnanolone in women with premenstrual syndrome
9. The importance of being dehydroepiandrosterone sulfate (in the blood of primates): A longer and healthier life?
10. Neuroactive steroids: Potential therapeutic use in neurological and psychiatric disorders